Perissos Private Wealth Management LLC Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

Perissos Private Wealth Management LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 512 shares of the healthcare conglomerate’s stock, valued at approximately $259,000.

Other large investors have also recently made changes to their positions in the company. International Assets Investment Management LLC increased its stake in UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after buying an additional 5,290,025 shares in the last quarter. Accredited Investors Inc. boosted its holdings in shares of UnitedHealth Group by 9,235.4% during the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after purchasing an additional 776,516 shares during the last quarter. Raymond James & Associates boosted its holdings in shares of UnitedHealth Group by 33.1% during the 3rd quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock valued at $1,380,661,000 after purchasing an additional 587,088 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its holdings in shares of UnitedHealth Group by 129.7% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock valued at $601,951,000 after purchasing an additional 581,324 shares during the last quarter. Finally, State Street Corp lifted its holdings in shares of UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after acquiring an additional 563,554 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. 0.33% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages recently commented on UNH. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a report on Friday, January 10th. UBS Group decreased their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Price Performance

NYSE UNH opened at $533.99 on Wednesday. The firm’s fifty day simple moving average is $527.67 and its two-hundred day simple moving average is $564.22. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm has a market capitalization of $491.42 billion, a P/E ratio of 34.45, a P/E/G ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.83 earnings per share. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.